Skip to Navigation
Home
News
Contact
US Military
HIV Research Program
Search
Home
About Us
Leadership
Nelson Michael, M.D., Ph.D. _ NEW
Merlin Robb, M.D.
Julie Ake, M.D.
Kayvon Modjarrad, M.D., Ph.D.
Sheila Peel, MSPH, Ph.D.
Paul Scott, M.D., M.P.H.
Robert Gramzinski, PhD
Nelson Michael, M.D., Ph.D. _ NEW
Our Scientists
Carl Alving, M.D.
Jintanat Ananworanich
Diane Bolton, Ph.D.
Michael Eller, Ph.D.
Gary Matyas, Ph.D.
Morgane Rolland
Fred Sawe, MBCHB, MMED
Rasmi Thomas, Ph.D.
Sodsai Tovanabutra, M.Sc
Lydie Trautmann, Ph.D.
Dr. Lydie Trautmann: Lab Members
Dr. Lydie Trautmann: Selected Publications
Sandhya Vasan, M.D.
Alexandra Schuetz, Ph.D.
Alexandra Schuetz, Ph.D.
M. Gordon Joyce, B.Sc. (Hons), Ph.D.
Mangala Rao
Mark Manak, Ph.D.
Shelly Krebs, Ph.D.
Victoria Polonis, Ph.D.
Contributions
WRAIR
Partners
Publications
2014 Publications
2009 Publications
2010 Publications
2011 Publications
2012 Publications
2013 Publications
2015 Publications
Research
Vaccine
MVA Vaccine
Other Vaccine Candidates
RV144 Trial
Remission
Early Capture HIV Cohort Study (ECHO) - RV217
RV 254/SEARCH10
Cohort Studies
AFRICOS
Other Cohorts Studies
RV368/TRUST
Threat Assesment
Diagnostics
Emerging Infections
Ebola Studies
MERS Studies
Zika Studies
Global Health Programs
PEPFAR
PMI
GHP Research
International Network
United States
Thailand
Kenya
Mozambique
Nigeria
Tanzania
Uganda
News
Media Room
Study examins long-term adverse health effects of Ebola survivors
RV144 Vaccine Efficacy Increased Against Certain HIV Viruses
Early HIV Infection Study Offers Insight Into the Initial Stages of HIV Infection
Joint West Africa Research Group
Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic In Africa
Zika Vaccine Development
MHRP in the News
Newsletters
Fact Sheets
MHRP Overview
MHRP Brochure
Military Medicine: Building on a Tradition of Success in Infectious Diseases
$6.3 M Awarded for the Production of an HIV-1 Subtype C gp145 Env Candidate Vaccine Developed by MHRP Scientists
2010 International AIDS Conference, Vienna, Austria
2010 International Military HIV/AIDS Conference
2010 MHRP World Aids Day Activities
A Day in the Life of a Nigerian Study Nurse
A Foucus on Acute Infection Studies
A Foucus on Acute Infection Studies
A Trip to Koome Island
A Vaccine to Prevent Zika Infection in Humans is Feasible
AFRIMS Celebrates 50 Years of Medical Research In Thailand
AIDS 2012
AIDS Vaccine 2012
AIDS Vaccine Conference 2009
AIDS Vaccine Researchers Gather in Thailand for Annual Vaccine Conference
Ambassador Goosby Site Visit
At the Frontlines of an Epidemic: Combating Ebola in Liberia
At the Frontlines of an Epidemic: Combating Ebola in Liberia
Bioethics Commission Urges US to Adopt Ethical Approach to Ebola & Health Preparedness
Biomarkers of Disease Progression Appear to Differ in Sub-Saharan Population
Bringing Health Services to the People
Bringing Health Services to the People
Building on RV144: HIV Vaccien Trial Launches in South Africa
COL Kim Provides Commentary for Series, "30 years in 30 weeks"
CROI 2012 Wrap Up
CROI 2013 Wrap-up
Capt. Darrell Singer Recognized for His Exceptional Contributions to PEPFAR
Caring for the Children Left Behind by HIV
Clinical center expands and enhances care in Mbeya, Tanzania
Collaborative Efforts to Combat Malaria in Tanzania
Community Events Promote HIV Vaccine Awareness in Kenya
Community Relations: Uganda Participates in Kampala Marathon
Community and Media Events Promote Vaccine Importance in Uganda
Comprehensive New Framework to Speed and Enhance HIV Research
Congressional Delegation Visits MHRP Site in Kericho, Kenya
Contraception Use During HIV Vaccine Trial
DoD Leadership Visits MHRP's Nigeria Research Site
Dr. Jintanat Ananworanich Recieves Princess Soamsawali's Award in Thailand
Dr. Jintanat Ananworanich Recieves Princess Soamsawali's Award in Thailand
Duke and MHRP Win Award for Best Academic Research Team
Early Infant Diagnosis and Rapid Treatment Key to Meeting UNAIDS 90-90-90 Targets
Early Study Shows MHRP Vaccine Candidate, MVA-CMDR, Safe and Immunogenic
Early antiretroviral therapy dramatically reduces HIV DNA set point
Early-Capture HIV Study Allows for Characterization of Acute Infection Period
Family day at an HIV clinic in Tanzania
Findings from WRAIR-NIAID EBOV Clinical Trial Published in NEJM
Findings from WRAIR-NIAID EBOV Clinical Trial Published in NEJM
Army-developed Zika Vaccine Induces Strong Immune Response in Three Phase 1 Studies
Characterization of T Cells Infected with Simian Immunodeficiency Virus Reveals Host-pathogen Interactions
DREAMS Work in Mbeya Provides a Path Out of Prostitution
Experimental Vaccine Blocks Effects of Heroin in Mice
MHRP Scientists and Collaborators Presenting at CROI 2018
MHRP Scientists and Collaborators at the ASTMH Annual Meeting
RNA Signatures of Natural Killer Immune Cells Suggest Increased Activity Following HIV Vaccination
Social Science Research Involving MHRP Acute HIV Infection Cohort Seeks to Understand Volunteers' Perspectives in Treatment Interruption Studies
Study Links Gut-Homing Protein Levels With HIV Infection Risk, Disease Progression
World AIDS Day 2017
Clinical Training Course in Liberia Boosts Biopreparedness Efforts in West Africa
Col. Nelson Michael Selected as One of Vice Motherboard’s ‘Humans of the Year’
Diagnosis of Acute HIV Infection and Immediate Treatment Reduces Transmission by 89% in Thai Cohort
Dr. Carl Alving Inducted as National Academy of Inventors Fellow
Dr. Lydie Trautmann Awarded R01 Grant from National Institute of Mental Health
Dual-use Heroin Vaccine Elicits Immune Response in Mice
Experts identify challenges to fast-track development of Zika vaccine
First Public Meeting of Cross-Sector HIV Cure Project
Human Trials Begin for Army-Developed Zika Purified Inactivated Virus (ZPIV) Vaccine
Initiating ART During Acute HIV Infection Affects Trajectory of Viral Load
Insight into Acute HIV Infection
Investigational HIV Therapeutic Vaccine Approach Helps Control SIV in Preclinical Studies
Joint West Africa Research Group Begins Infectious Disease Surveillance Study in Nigeria
Koome Island Demonstration Farm Helps Support Women and Families
Late HIV Vaccine Boost Elicits Higher Immune Response in Volunteers from the RV144 Thai Trial
MHRP Researchers and Collaborators Presenting at CROI 2017
MHRP Welcomes Dr. M. Gordon Joyce, Chief of New Structural Biology Lab Section
MHRP and Collaborators at HIV Research for Prevention (HIVR4P) 2016
MHRP and Collaborators at the 9th IAS Conference on HIV Science
MHRP scientists and collaborators detect declining trend in transmitted drug resistance in acute HIV infection cohort
New MHRP PEPFAR-funded study to examine malaria and TB HIV co-infection in Kenyan Defence Forces
New Multi-site Phase 2 Ebola Vaccine Study Begins in Africa
New Study Provides Clues to Early T Cell Immune Responses in Acute HIV Infection
Nigeria Biopreparedness Initiative Launches with Laboratory Training and Site Assessment
Nigeria Study Identifies Potential Cohorts for HIV Vaccine Development
U.S. Officials Visit with Participants in DREAMS Program
World AIDS Day 2016: Reinvigorating the Field
World TB Day: MHRP Research Physician Focuses on Problem of TB/HIV Co-infection
First-in-Human Phase 1 Clinical Trial of MERS Vaccine Begins
Fitness training and events help increase HIV prevention awareness in Kenya
Follow-up Study to RV144 HIV Vaccine Trial Shows No Effect on Disease Progression in Infected Volunteers
Former MHRP Leader Selected as Next U.S. Global AIDS Coordinator
Former MHRP Leader Selected as Next U.S. Global AIDS Coordinator
Future of HIV Cure Research Points to Combination Approach
HIV Infant Tracking System (HITSystem) Improves Early Infant Diagnosis Outcomes for HIV-Exposed Infants in Tanzania
HIV Prevention, Care and Treatment Open House Draws Thousands to Tanzania's Southern Highlands
HIV Vaccine Awareness Day 2009
HIV Vaccine Awareness Day 2010
HIV Vaccine Awareness Day 2011
HIV Vaccine Awareness Day 2011 Activities
HIV Vaccine Awareness Day: Building on the Success of RV144
HIV Vaccine Development and the US Military
HIV Vaccine Development and the US Military
HIV Vaccine Research Center of Excellence to Open at AFRIMS
HIV-1 Immune Evasion Mutations Could Impact Future Vaccine Efficacy
How the Military is Engaged in the Battle Against Malaria
How the Military is Engaged in the Battle Against Malaria
Human Clinical Trial of DNA-MVA HIV Vaccine Candidate Begins
Human Clinical Trial of a New DNA-MVA Vaccine Candidate Begins in Africa
Human Genetic Studies Underscore Similarities Among East African Populations
Humanized DRAG Mouse Model Holds Promise For Pre-Clinical Testing of Candidate HIV Vaccines
IRIS Study Opens in Kericho, Kenya
Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya
In Memory of Sen. Daniel K. Inouye
In Memory of our Nigerian Colleagues
In South Africa, RV144 HIV Vaccine Regimen Induces Immune Responses Similiar to Those Seen in Thailand
In Uganda, MHRP Researchers Find Viral Burden to be Primary Predictor of HIV Disease Progression
In Uganda, MHRP Researchers Find Viral Burden to be Primary Predictor of HIV Disease Progression
Infection with Multiple HIV-1 Variants Leads to Poorer Clinical Outcomes
Initiation of ART during Acute HIV Infection Leads to High Rate of Non-Reactive HIV Serology
Innovative "Moonlight" HIV Counseling and Testing
Interview with Ambassador Goosby, U.S. Global AIDS Coordinator
Joint West Africa Research Group to Foster Biopreparedness
Joint West Africa research Group Completes First Training in Nigeria
Laboratory Studies Provide Possible Explanation for How the RV144 Vaccine Regimen May Have Protected Against HIV
Laboratory Training Program Brings Together MHRP, Nigerian Military and the U.S. Public Health Service
Lancet Article Explores Efficacy Variables in RV144
Large Multinational HIV Cohort Study Begins in Africa
Long-term Adverse Health Effects of Ebola Survivors Examined in New Lancet ID Paper
MHRP Collaborates with Maryland's Institute of Human Virology on Promising HIV/AIDS Vaccine Candidate
MHRP Community Engagement Meeting held in Uganda
MHRP Congratulates COL Jerome Kim on Top IVI Appointment
MHRP Congratulates COL Jerome Kim on Top IVI Appointment
MHRP Congratulates COL Jerome Kim on Top IVI Appointment
MHRP Congratulates COL Jerome Kim on Top IVI Appointment
MHRP Deputy Col. Jerome Kim Receives Award for Research Excellence
MHRP Diagnostics: A Unique Capability within the DoD
MHRP Diagnostics: A Unique Capability within the DoD
MHRP Director receives the Hero of Military Medicine Award for the U.S. Army
MHRP Kenya Country Director Receives Prestigious Military Civilian Award
MHRP Launches New Quarterly Newsletter
MHRP Leadership Meets with the President of Tanzania
MHRP Marks HIV Vaccine Awareness Day
MHRP Named a Clinical Trials Unit for NIH HIV/AIDS Clinical Trials Networks
MHRP Partners with Tanzanian People's Defense Forces to Open HIV Counseling and Testing Center
MHRP Profiles
MHRP Profiles
MHRP Profiles: Ebola Vaccine Trial Participant
MHRP Researcher Receives HIV Prevention Research Advocacy Fellowship
MHRP Researchers Provide Insight into Worlds Most Potent Vaccine Adjuvant
MHRP Researchers Provide Insight into Worlds Most Potent Vaccine Adjuvant
MHRP Researchers find Host Genetics Played a Role in RV144 Protection
MHRP Researchers find Host Genetics Played a Role in RV144 Protection
MHRP Scientist Discusses WHO Ebola Collaboration
MHRP Scientist Wins 2012 NIDA Avant-Garde Award for Combination Anti-Heroin/HIV Vaccine
MHRP Scientists Take Part in AIDS Vaccine 2010 Conference in Atlanta
MHRP Scientists and Collaborators Presenting at AIDS 2016
MHRP Scientists and Collaborators Presenting at CROI 2016
MHRP Welcomes Dr. Hendrik Streeck
MHRP Welcomes Dr. Jintanat Ananworanich as Associate Director for Therapeutics Research
MHRP Welcomes Lydie Trautmann, Chief of Cellular Immunology
MHRP Welcomes Lydie Trautmann, Chief of Cellular Immunology
MHRP and Collaborators Presenting at Keystone Symposia HIV Vaccine and HIV Persistence Meetings
MHRP and Colleagues Featured in Special JAIDS Supplement
MHRP at AIDS Vaccine 2013
MHRP at CROI 2014
MHRP at CROI 2014
MHRP at HIV Research for Prevenetion (R4P) 2014
MHRP at HIV Research for Prevenetion (R4P) 2014
MHRP in the News: September 2011
MHRP selected by the AIDS Clinical Trials Group (ACTG) as a Clinical Trials Unit
MHRP's Administrative Offices Have Moved
MUWRP Celebrates Ten Years of Progress
MUWRP Provides Safe Male Circumcision at Uganda's Parliament Health Week
Making HIV Services More Accessible: MUWRP Refurbishes a Health Centre for the People of Koome Island
Microbicide Gel Shows Reduced Risk of HIV and Herpes Infection in Women
Mobile Diagnostic Lab May Help Combat TB and HIV in Tanzania
Moving Forward this HIV Vaccine Awareness Day
New Clinical Research Center and Comprehensive Care Center Open in Kericho
New Cohort Study Begins in Mozambique
New Cohort Study Begins in Mozambique
New Data from MHRP Study Impacts Rapid Hepatitis C Test Used on Battlefield
New Defence Reference Laboratory Commissioned in Nigeria
New District Youth Center Opens in Uganda
New Ebola vaccine study begins in Nigeria
New HIV Counseling and Testing Clinic Opens in Tanzania
New Insight into Selective Binding Properties of Infectious HIV
New Journal of Virus Eradication Launches Today
New Journal of Virus Eradication Launches Today
New Medical Male Circumcision Program Launched in Uganda
New Mobile Circumcision Clinic is Officially Launched with a Ribbon Cutting Ceremony
New Program in Tanzania Aims to Respond to and Reduce Gender Based Violence
New Report Lauds DoD Overseas Research Laboratories
New Studies Enhance Knowledge of Antibodies in HIV Vaccine Trials
New Studies Enhance Knowledge of Antibodies in HIV Vaccine Trials
New Study Aims to Better Understand Hepatitis Infection in Deployed U.S. Forces
New Study Provides Additional Insights into V2 Antibodies in the RV144 Trial
New Study Shows a Novel Antibody That Binds to Intracellular Lipids and Inhibits HIV Infection
New Study, RV306, Begins Screening in Thailand
New TB Lab Accredited in Tanzania
New findings provide insight into HIV epidemic in the U.S. Army
New study highlights need for Hepatitis C screening for U.S. military
New study shows increase in Kenyan HIV subtypes
New study shows that antibodies seen in RV144 may also correlate with lower risk of infection from multiple HIV subtypes
New study shows that antibodies seen in RV144 may also correlate with lower risk of infection from multiple HIV subtypes
Nigeria Unveils 2012 National HIV Vaccine Plan
OCTANE Study Influences Revision of WHO Guidelines for Treating Some HIV-Infected Women
PEPFAR Program Representatives Gather in Kenya to Share Successes and Plan for the Future
PEPFAR Releases Fifth Annual Report to Congress
PEPFAR's Impact After 10 Years
Paper published on Phase I/II Study of a Vaccine Candidate in East Africa
Patients with Advanced HIV and Tuberculosis May Benefit from Starting Antiretroviral Therapy Early
Phase Ib Ebola/Marburg Vaccine Clinical Trial Begins
Political Engagement: Tanzania
Pox-Protein Public-Private Partnership
Pox-Protein Public-Private Partnership
President's Bioethics Commmission Released Its Report on Human Subjects Protection
Presidential Commission for the Study of Bioethical Issues
Promising Results of Novel Combination HIV Vaccine
Promising Results of Novel Combination HIV Vaccine
Prospects for a Globally Effective HIV-1 Vaccine
Publication Supplements
RV144 Follow-up Study RV305 Begins in Thailand
RV144 Update at CROI
RV144 Vaccine Efficacy Increased Against Certain HIV Viruses
RV144 Vaccine Regimen Tops Best of Lists in 2009
RV144: Further Research is Underway
RV144: The Search for Correlates of Protection Begins
Researchers Design Global HIV Vaccine that Shows Promise in Early Studies
Researchers Determine Factors Associated with Elevated Viral Load Setpoint in Sub-Saharan Africa
Researchers Identify Gene Variant Associated with Protection from HIV in Tanzania
Researchers Identify New Generic Vaccine Adjuvants
Researchers Induce HIV-neutralizing Antibodies by Immunization that Recognize both HIV-1 Envelope Protein and Lipids
Researchers find multiple co-circulating HIV-1 subtypes in North Africa and Middle East
Risk of Acquiring a Transfusion-Transmitted Infection Found to be Low for Military Personnel Who Receive Blood on the Battlefield
SAMRMC Wins Research and Development Lab of the Year
Safe Male Circumcision Services Now Offered at the Mukono Health Center, Uganda
Senior State Department Leadership Visit Nigeria Sites
Socioeconomic Impacts of Antiretroviral Therapy and Gender
State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
Statement from the Military HIV Research Program on World AIDS Day 2011
Statement on World AIDS Day 2012
Study Compares Hospitalization Rates Among HIV Controllers and Those With Medically Controlled HIV in Military Cohort
Study Finds HIV Vaccine Influences the Genetic Makeup of the Virus
Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic in Africa
Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic in Africa
Study finds low ART treatment costs and good retention at clinics in Kenya
TB and HIV: A Deadly Combinaton
TB and HIV: A Deadly Combinaton
Tanzania President Dedicates Mobile Diagnostic Lab
Tanzanian President Jakaya Kikwete Visits the Walter Reed Army Institute of Research
Thai Government To Support HIV Vaccine Study
The Important and Varied Role of Nurses in HIV Research
The Important and Varied Role of Nurses in HIV Research
The U.S. and Tanzanian People's Defence Forces Formalize Arrangement to Conduct HIV Care and Treatment Activities in Tanzania
Time for an HIV Vaccine
Tragic Loss for The HIV Research Community
Tragic Loss for The HIV Research Community
Training for HIV diagnosis and treatment monitoring in Nigeria
Two New Neutralizing Antibodies Discovered
U.S. Ambassador to Nigeria Visits Defense Health Club
U.S. Ambassador to Tanzania Visits MHRP site in Mbeya
U.S. Army Part of Team to Win HIV Cure Research Grant
US Army Announces Results of the Landmark RV144 Trial
US Army Announces Results of the Landmark RV144 Trial
Ugandan Medical Male Circumcision Program Launched to Prevent HIV Transmission
Ugandan Youth Create Murals to Help Promote HIV Prevention
Update on RV144
Vaccine Candidates Protect Against Zika Virus in Rhesus Monkeys
Vaccine Partially Protects Monkeys from HIV-like Infection
Very early seeding of SIV viral reservoir found
Very early seeding of SIV viral reservoir found
WRAIR Teams with Sanofi Pasteur to Co-Develop Zika Virus Vaccine
Walter Reed Army Institute of Research Begins New Phase 2 Clinical Trial of Ebola Vaccine Regimens
Walter Reed Program - Nigeria Celebrates the Opening of a New Office
World AIDS Day 2013
World AIDS Day 2015: The Time to Act is Now
World AIDS Day Events
World AIDS Day: Accelerating the Hunt for An Effective HIV Vaccine
World AIDS Day: Accelerating the Hunt for An Effective HIV Vaccine
World TB Day: MHRP Research Physician Examines Overlap in HIV and Tuberculosis
iPrEx study on Pre-Exposure Prophylaxis (PrEP) Shows Some Effectiveness in Preventing HIV
iPrEx study on Pre-Exposure Prophylaxis (PrEP) Shows Some Effectiveness in Preventing HIV
Careers
Current Positions
Meet Our People
Kim Bonhice
Sandhya Vasan, M.D.
Contact
You are here
Home
News
Media Room
Joint West Africa Research Group
Joint West Africa Research Group
News
Media Room
MHRP in the News
Newsletters
Fact Sheets
$6.3 M Awarded for the Production of an HIV-1 Subtype C gp145 Env Candidate Vaccine Developed by MHRP Scientists
2010 International AIDS Conference, Vienna, Austria
2010 International Military HIV/AIDS Conference
2010 MHRP World Aids Day Activities
A Day in the Life of a Nigerian Study Nurse
A Foucus on Acute Infection Studies
A Foucus on Acute Infection Studies
A Trip to Koome Island
A Vaccine to Prevent Zika Infection in Humans is Feasible
AFRIMS Celebrates 50 Years of Medical Research In Thailand
AIDS 2012
AIDS Vaccine 2012
AIDS Vaccine Conference 2009
AIDS Vaccine Researchers Gather in Thailand for Annual Vaccine Conference
Ambassador Goosby Site Visit
At the Frontlines of an Epidemic: Combating Ebola in Liberia
At the Frontlines of an Epidemic: Combating Ebola in Liberia
Bioethics Commission Urges US to Adopt Ethical Approach to Ebola & Health Preparedness
Biomarkers of Disease Progression Appear to Differ in Sub-Saharan Population
Bringing Health Services to the People
Bringing Health Services to the People
Building on RV144: HIV Vaccien Trial Launches in South Africa
COL Kim Provides Commentary for Series, "30 years in 30 weeks"
CROI 2012 Wrap Up
CROI 2013 Wrap-up
Capt. Darrell Singer Recognized for His Exceptional Contributions to PEPFAR
Caring for the Children Left Behind by HIV
Clinical center expands and enhances care in Mbeya, Tanzania
Collaborative Efforts to Combat Malaria in Tanzania
Community Events Promote HIV Vaccine Awareness in Kenya
Community Relations: Uganda Participates in Kampala Marathon
Community and Media Events Promote Vaccine Importance in Uganda
Comprehensive New Framework to Speed and Enhance HIV Research
Congressional Delegation Visits MHRP Site in Kericho, Kenya
Contraception Use During HIV Vaccine Trial
DoD Leadership Visits MHRP's Nigeria Research Site
Dr. Jintanat Ananworanich Recieves Princess Soamsawali's Award in Thailand
Dr. Jintanat Ananworanich Recieves Princess Soamsawali's Award in Thailand
Duke and MHRP Win Award for Best Academic Research Team
Early Infant Diagnosis and Rapid Treatment Key to Meeting UNAIDS 90-90-90 Targets
Early Study Shows MHRP Vaccine Candidate, MVA-CMDR, Safe and Immunogenic
Early antiretroviral therapy dramatically reduces HIV DNA set point
Early-Capture HIV Study Allows for Characterization of Acute Infection Period
Family day at an HIV clinic in Tanzania
Findings from WRAIR-NIAID EBOV Clinical Trial Published in NEJM
Findings from WRAIR-NIAID EBOV Clinical Trial Published in NEJM
Army-developed Zika Vaccine Induces Strong Immune Response in Three Phase 1 Studies
Characterization of T Cells Infected with Simian Immunodeficiency Virus Reveals Host-pathogen Interactions
DREAMS Work in Mbeya Provides a Path Out of Prostitution
Experimental Vaccine Blocks Effects of Heroin in Mice
MHRP Scientists and Collaborators Presenting at CROI 2018
MHRP Scientists and Collaborators at the ASTMH Annual Meeting
RNA Signatures of Natural Killer Immune Cells Suggest Increased Activity Following HIV Vaccination
Social Science Research Involving MHRP Acute HIV Infection Cohort Seeks to Understand Volunteers' Perspectives in Treatment Interruption Studies
Study Links Gut-Homing Protein Levels With HIV Infection Risk, Disease Progression
World AIDS Day 2017
Clinical Training Course in Liberia Boosts Biopreparedness Efforts in West Africa
Col. Nelson Michael Selected as One of Vice Motherboard’s ‘Humans of the Year’
Diagnosis of Acute HIV Infection and Immediate Treatment Reduces Transmission by 89% in Thai Cohort
Dr. Carl Alving Inducted as National Academy of Inventors Fellow
Dr. Lydie Trautmann Awarded R01 Grant from National Institute of Mental Health
Dual-use Heroin Vaccine Elicits Immune Response in Mice
Experts identify challenges to fast-track development of Zika vaccine
First Public Meeting of Cross-Sector HIV Cure Project
Human Trials Begin for Army-Developed Zika Purified Inactivated Virus (ZPIV) Vaccine
Initiating ART During Acute HIV Infection Affects Trajectory of Viral Load
Insight into Acute HIV Infection
Investigational HIV Therapeutic Vaccine Approach Helps Control SIV in Preclinical Studies
Joint West Africa Research Group Begins Infectious Disease Surveillance Study in Nigeria
Koome Island Demonstration Farm Helps Support Women and Families
Late HIV Vaccine Boost Elicits Higher Immune Response in Volunteers from the RV144 Thai Trial
MHRP Researchers and Collaborators Presenting at CROI 2017
MHRP Welcomes Dr. M. Gordon Joyce, Chief of New Structural Biology Lab Section
MHRP and Collaborators at HIV Research for Prevention (HIVR4P) 2016
MHRP and Collaborators at the 9th IAS Conference on HIV Science
MHRP scientists and collaborators detect declining trend in transmitted drug resistance in acute HIV infection cohort
New MHRP PEPFAR-funded study to examine malaria and TB HIV co-infection in Kenyan Defence Forces
New Multi-site Phase 2 Ebola Vaccine Study Begins in Africa
New Study Provides Clues to Early T Cell Immune Responses in Acute HIV Infection
Nigeria Biopreparedness Initiative Launches with Laboratory Training and Site Assessment
Nigeria Study Identifies Potential Cohorts for HIV Vaccine Development
U.S. Officials Visit with Participants in DREAMS Program
World AIDS Day 2016: Reinvigorating the Field
World TB Day: MHRP Research Physician Focuses on Problem of TB/HIV Co-infection
First-in-Human Phase 1 Clinical Trial of MERS Vaccine Begins
Fitness training and events help increase HIV prevention awareness in Kenya
Follow-up Study to RV144 HIV Vaccine Trial Shows No Effect on Disease Progression in Infected Volunteers
Former MHRP Leader Selected as Next U.S. Global AIDS Coordinator
Former MHRP Leader Selected as Next U.S. Global AIDS Coordinator
Future of HIV Cure Research Points to Combination Approach
HIV Infant Tracking System (HITSystem) Improves Early Infant Diagnosis Outcomes for HIV-Exposed Infants in Tanzania
HIV Prevention, Care and Treatment Open House Draws Thousands to Tanzania's Southern Highlands
HIV Vaccine Awareness Day 2009
HIV Vaccine Awareness Day 2010
HIV Vaccine Awareness Day 2011
HIV Vaccine Awareness Day 2011 Activities
HIV Vaccine Awareness Day: Building on the Success of RV144
HIV Vaccine Development and the US Military
HIV Vaccine Development and the US Military
HIV Vaccine Research Center of Excellence to Open at AFRIMS
HIV-1 Immune Evasion Mutations Could Impact Future Vaccine Efficacy
How the Military is Engaged in the Battle Against Malaria
How the Military is Engaged in the Battle Against Malaria
Human Clinical Trial of DNA-MVA HIV Vaccine Candidate Begins
Human Clinical Trial of a New DNA-MVA Vaccine Candidate Begins in Africa
Human Genetic Studies Underscore Similarities Among East African Populations
Humanized DRAG Mouse Model Holds Promise For Pre-Clinical Testing of Candidate HIV Vaccines
IRIS Study Opens in Kericho, Kenya
Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya
In Memory of Sen. Daniel K. Inouye
In Memory of our Nigerian Colleagues
In South Africa, RV144 HIV Vaccine Regimen Induces Immune Responses Similiar to Those Seen in Thailand
In Uganda, MHRP Researchers Find Viral Burden to be Primary Predictor of HIV Disease Progression
In Uganda, MHRP Researchers Find Viral Burden to be Primary Predictor of HIV Disease Progression
Infection with Multiple HIV-1 Variants Leads to Poorer Clinical Outcomes
Initiation of ART during Acute HIV Infection Leads to High Rate of Non-Reactive HIV Serology
Innovative "Moonlight" HIV Counseling and Testing
Interview with Ambassador Goosby, U.S. Global AIDS Coordinator
Joint West Africa Research Group to Foster Biopreparedness
Joint West Africa research Group Completes First Training in Nigeria
Laboratory Studies Provide Possible Explanation for How the RV144 Vaccine Regimen May Have Protected Against HIV
Laboratory Training Program Brings Together MHRP, Nigerian Military and the U.S. Public Health Service
Lancet Article Explores Efficacy Variables in RV144
Large Multinational HIV Cohort Study Begins in Africa
Long-term Adverse Health Effects of Ebola Survivors Examined in New Lancet ID Paper
MHRP Collaborates with Maryland's Institute of Human Virology on Promising HIV/AIDS Vaccine Candidate
MHRP Community Engagement Meeting held in Uganda
MHRP Congratulates COL Jerome Kim on Top IVI Appointment
MHRP Congratulates COL Jerome Kim on Top IVI Appointment
MHRP Congratulates COL Jerome Kim on Top IVI Appointment
MHRP Congratulates COL Jerome Kim on Top IVI Appointment
MHRP Deputy Col. Jerome Kim Receives Award for Research Excellence
MHRP Diagnostics: A Unique Capability within the DoD
MHRP Diagnostics: A Unique Capability within the DoD
MHRP Director receives the Hero of Military Medicine Award for the U.S. Army
MHRP Kenya Country Director Receives Prestigious Military Civilian Award
MHRP Launches New Quarterly Newsletter
MHRP Leadership Meets with the President of Tanzania
MHRP Marks HIV Vaccine Awareness Day
MHRP Named a Clinical Trials Unit for NIH HIV/AIDS Clinical Trials Networks
MHRP Partners with Tanzanian People's Defense Forces to Open HIV Counseling and Testing Center
MHRP Profiles
MHRP Profiles
MHRP Profiles: Ebola Vaccine Trial Participant
MHRP Researcher Receives HIV Prevention Research Advocacy Fellowship
MHRP Researchers Provide Insight into Worlds Most Potent Vaccine Adjuvant
MHRP Researchers Provide Insight into Worlds Most Potent Vaccine Adjuvant
MHRP Researchers find Host Genetics Played a Role in RV144 Protection
MHRP Researchers find Host Genetics Played a Role in RV144 Protection
MHRP Scientist Discusses WHO Ebola Collaboration
MHRP Scientist Wins 2012 NIDA Avant-Garde Award for Combination Anti-Heroin/HIV Vaccine
MHRP Scientists Take Part in AIDS Vaccine 2010 Conference in Atlanta
MHRP Scientists and Collaborators Presenting at AIDS 2016
MHRP Scientists and Collaborators Presenting at CROI 2016
MHRP Welcomes Dr. Hendrik Streeck
MHRP Welcomes Dr. Jintanat Ananworanich as Associate Director for Therapeutics Research
MHRP Welcomes Lydie Trautmann, Chief of Cellular Immunology
MHRP Welcomes Lydie Trautmann, Chief of Cellular Immunology
MHRP and Collaborators Presenting at Keystone Symposia HIV Vaccine and HIV Persistence Meetings
MHRP and Colleagues Featured in Special JAIDS Supplement
MHRP at AIDS Vaccine 2013
MHRP at CROI 2014
MHRP at CROI 2014
MHRP at HIV Research for Prevenetion (R4P) 2014
MHRP at HIV Research for Prevenetion (R4P) 2014
MHRP in the News: September 2011
MHRP selected by the AIDS Clinical Trials Group (ACTG) as a Clinical Trials Unit
MHRP's Administrative Offices Have Moved
MUWRP Celebrates Ten Years of Progress
MUWRP Provides Safe Male Circumcision at Uganda's Parliament Health Week
Making HIV Services More Accessible: MUWRP Refurbishes a Health Centre for the People of Koome Island
Microbicide Gel Shows Reduced Risk of HIV and Herpes Infection in Women
Mobile Diagnostic Lab May Help Combat TB and HIV in Tanzania
Moving Forward this HIV Vaccine Awareness Day
New Clinical Research Center and Comprehensive Care Center Open in Kericho
New Cohort Study Begins in Mozambique
New Cohort Study Begins in Mozambique
New Data from MHRP Study Impacts Rapid Hepatitis C Test Used on Battlefield
New Defence Reference Laboratory Commissioned in Nigeria
New District Youth Center Opens in Uganda
New Ebola vaccine study begins in Nigeria
New HIV Counseling and Testing Clinic Opens in Tanzania
New Insight into Selective Binding Properties of Infectious HIV
New Journal of Virus Eradication Launches Today
New Journal of Virus Eradication Launches Today
New Medical Male Circumcision Program Launched in Uganda
New Mobile Circumcision Clinic is Officially Launched with a Ribbon Cutting Ceremony
New Program in Tanzania Aims to Respond to and Reduce Gender Based Violence
New Report Lauds DoD Overseas Research Laboratories
New Studies Enhance Knowledge of Antibodies in HIV Vaccine Trials
New Studies Enhance Knowledge of Antibodies in HIV Vaccine Trials
New Study Aims to Better Understand Hepatitis Infection in Deployed U.S. Forces
New Study Provides Additional Insights into V2 Antibodies in the RV144 Trial
New Study Shows a Novel Antibody That Binds to Intracellular Lipids and Inhibits HIV Infection
New Study, RV306, Begins Screening in Thailand
New TB Lab Accredited in Tanzania
New findings provide insight into HIV epidemic in the U.S. Army
New study highlights need for Hepatitis C screening for U.S. military
New study shows increase in Kenyan HIV subtypes
New study shows that antibodies seen in RV144 may also correlate with lower risk of infection from multiple HIV subtypes
New study shows that antibodies seen in RV144 may also correlate with lower risk of infection from multiple HIV subtypes
Nigeria Unveils 2012 National HIV Vaccine Plan
OCTANE Study Influences Revision of WHO Guidelines for Treating Some HIV-Infected Women
PEPFAR Program Representatives Gather in Kenya to Share Successes and Plan for the Future
PEPFAR Releases Fifth Annual Report to Congress
PEPFAR's Impact After 10 Years
Paper published on Phase I/II Study of a Vaccine Candidate in East Africa
Patients with Advanced HIV and Tuberculosis May Benefit from Starting Antiretroviral Therapy Early
Phase Ib Ebola/Marburg Vaccine Clinical Trial Begins
Political Engagement: Tanzania
Pox-Protein Public-Private Partnership
Pox-Protein Public-Private Partnership
President's Bioethics Commmission Released Its Report on Human Subjects Protection
Presidential Commission for the Study of Bioethical Issues
Promising Results of Novel Combination HIV Vaccine
Promising Results of Novel Combination HIV Vaccine
Prospects for a Globally Effective HIV-1 Vaccine
Publication Supplements
RV144 Follow-up Study RV305 Begins in Thailand
RV144 Update at CROI
RV144 Vaccine Efficacy Increased Against Certain HIV Viruses
RV144 Vaccine Regimen Tops Best of Lists in 2009
RV144: Further Research is Underway
RV144: The Search for Correlates of Protection Begins
Researchers Design Global HIV Vaccine that Shows Promise in Early Studies
Researchers Determine Factors Associated with Elevated Viral Load Setpoint in Sub-Saharan Africa
Researchers Identify Gene Variant Associated with Protection from HIV in Tanzania
Researchers Identify New Generic Vaccine Adjuvants
Researchers Induce HIV-neutralizing Antibodies by Immunization that Recognize both HIV-1 Envelope Protein and Lipids
Researchers find multiple co-circulating HIV-1 subtypes in North Africa and Middle East
Risk of Acquiring a Transfusion-Transmitted Infection Found to be Low for Military Personnel Who Receive Blood on the Battlefield
SAMRMC Wins Research and Development Lab of the Year
Safe Male Circumcision Services Now Offered at the Mukono Health Center, Uganda
Senior State Department Leadership Visit Nigeria Sites
Socioeconomic Impacts of Antiretroviral Therapy and Gender
State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
Statement from the Military HIV Research Program on World AIDS Day 2011
Statement on World AIDS Day 2012
Study Compares Hospitalization Rates Among HIV Controllers and Those With Medically Controlled HIV in Military Cohort
Study Finds HIV Vaccine Influences the Genetic Makeup of the Virus
Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic in Africa
Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic in Africa
Study finds low ART treatment costs and good retention at clinics in Kenya
TB and HIV: A Deadly Combinaton
TB and HIV: A Deadly Combinaton
Tanzania President Dedicates Mobile Diagnostic Lab
Tanzanian President Jakaya Kikwete Visits the Walter Reed Army Institute of Research
Thai Government To Support HIV Vaccine Study
The Important and Varied Role of Nurses in HIV Research
The Important and Varied Role of Nurses in HIV Research
The U.S. and Tanzanian People's Defence Forces Formalize Arrangement to Conduct HIV Care and Treatment Activities in Tanzania
Time for an HIV Vaccine
Tragic Loss for The HIV Research Community
Tragic Loss for The HIV Research Community
Training for HIV diagnosis and treatment monitoring in Nigeria
Two New Neutralizing Antibodies Discovered
U.S. Ambassador to Nigeria Visits Defense Health Club
U.S. Ambassador to Tanzania Visits MHRP site in Mbeya
U.S. Army Part of Team to Win HIV Cure Research Grant
US Army Announces Results of the Landmark RV144 Trial
US Army Announces Results of the Landmark RV144 Trial
Ugandan Medical Male Circumcision Program Launched to Prevent HIV Transmission
Ugandan Youth Create Murals to Help Promote HIV Prevention
Update on RV144
Vaccine Candidates Protect Against Zika Virus in Rhesus Monkeys
Vaccine Partially Protects Monkeys from HIV-like Infection
Very early seeding of SIV viral reservoir found
Very early seeding of SIV viral reservoir found
WRAIR Teams with Sanofi Pasteur to Co-Develop Zika Virus Vaccine
Walter Reed Army Institute of Research Begins New Phase 2 Clinical Trial of Ebola Vaccine Regimens
Walter Reed Program - Nigeria Celebrates the Opening of a New Office
World AIDS Day 2013
World AIDS Day 2015: The Time to Act is Now
World AIDS Day Events
World AIDS Day: Accelerating the Hunt for An Effective HIV Vaccine
World AIDS Day: Accelerating the Hunt for An Effective HIV Vaccine
World TB Day: MHRP Research Physician Examines Overlap in HIV and Tuberculosis
iPrEx study on Pre-Exposure Prophylaxis (PrEP) Shows Some Effectiveness in Preventing HIV
iPrEx study on Pre-Exposure Prophylaxis (PrEP) Shows Some Effectiveness in Preventing HIV
Home
About Us
Leadership
Nelson Michael, M.D., Ph.D. _ NEW
Merlin Robb, M.D.
Julie Ake, M.D.
Kayvon Modjarrad, M.D., Ph.D.
Sheila Peel, MSPH, Ph.D.
Paul Scott, M.D., M.P.H.
Robert Gramzinski, PhD
Nelson Michael, M.D., Ph.D. _ NEW
Our Scientists
Carl Alving, M.D.
Jintanat Ananworanich
Diane Bolton, Ph.D.
Michael Eller, Ph.D.
Gary Matyas, Ph.D.
Morgane Rolland
Fred Sawe, MBCHB, MMED
Rasmi Thomas, Ph.D.
Sodsai Tovanabutra, M.Sc
Lydie Trautmann, Ph.D.
Dr. Lydie Trautmann: Lab Members
Dr. Lydie Trautmann: Selected Publications
Sandhya Vasan, M.D.
Alexandra Schuetz, Ph.D.
Alexandra Schuetz, Ph.D.
M. Gordon Joyce, B.Sc. (Hons), Ph.D.
Mangala Rao
Mark Manak, Ph.D.
Shelly Krebs, Ph.D.
Victoria Polonis, Ph.D.
Contributions
WRAIR
Partners
Publications
2014 Publications
2009 Publications
2010 Publications
2011 Publications
2012 Publications
2013 Publications
2015 Publications
Research
Vaccine
MVA Vaccine
Other Vaccine Candidates
RV144 Trial
Remission
Early Capture HIV Cohort Study (ECHO) - RV217
RV 254/SEARCH10
Cohort Studies
AFRICOS
Other Cohorts Studies
RV368/TRUST
Threat Assesment
Diagnostics
Emerging Infections
Ebola Studies
MERS Studies
Zika Studies
Global Health Programs
PEPFAR
PMI
GHP Research
International Network
United States
Thailand
Kenya
Mozambique
Nigeria
Tanzania
Uganda
News
Media Room
Study examins long-term adverse health effects of Ebola survivors
RV144 Vaccine Efficacy Increased Against Certain HIV Viruses
Early HIV Infection Study Offers Insight Into the Initial Stages of HIV Infection
Joint West Africa Research Group
Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic In Africa
Zika Vaccine Development
MHRP in the News
Newsletters
Fact Sheets
MHRP Overview
MHRP Brochure
Military Medicine: Building on a Tradition of Success in Infectious Diseases
$6.3 M Awarded for the Production of an HIV-1 Subtype C gp145 Env Candidate Vaccine Developed by MHRP Scientists
2010 International AIDS Conference, Vienna, Austria
2010 International Military HIV/AIDS Conference
2010 MHRP World Aids Day Activities
A Day in the Life of a Nigerian Study Nurse
A Foucus on Acute Infection Studies
A Foucus on Acute Infection Studies
A Trip to Koome Island
A Vaccine to Prevent Zika Infection in Humans is Feasible
AFRIMS Celebrates 50 Years of Medical Research In Thailand
AIDS 2012
AIDS Vaccine 2012
AIDS Vaccine Conference 2009
AIDS Vaccine Researchers Gather in Thailand for Annual Vaccine Conference
Ambassador Goosby Site Visit
At the Frontlines of an Epidemic: Combating Ebola in Liberia
At the Frontlines of an Epidemic: Combating Ebola in Liberia
Bioethics Commission Urges US to Adopt Ethical Approach to Ebola & Health Preparedness
Biomarkers of Disease Progression Appear to Differ in Sub-Saharan Population
Bringing Health Services to the People
Bringing Health Services to the People
Building on RV144: HIV Vaccien Trial Launches in South Africa
COL Kim Provides Commentary for Series, "30 years in 30 weeks"
CROI 2012 Wrap Up
CROI 2013 Wrap-up
Capt. Darrell Singer Recognized for His Exceptional Contributions to PEPFAR
Caring for the Children Left Behind by HIV
Clinical center expands and enhances care in Mbeya, Tanzania
Collaborative Efforts to Combat Malaria in Tanzania
Community Events Promote HIV Vaccine Awareness in Kenya
Community Relations: Uganda Participates in Kampala Marathon
Community and Media Events Promote Vaccine Importance in Uganda
Comprehensive New Framework to Speed and Enhance HIV Research
Congressional Delegation Visits MHRP Site in Kericho, Kenya
Contraception Use During HIV Vaccine Trial
DoD Leadership Visits MHRP's Nigeria Research Site
Dr. Jintanat Ananworanich Recieves Princess Soamsawali's Award in Thailand
Dr. Jintanat Ananworanich Recieves Princess Soamsawali's Award in Thailand
Duke and MHRP Win Award for Best Academic Research Team
Early Infant Diagnosis and Rapid Treatment Key to Meeting UNAIDS 90-90-90 Targets
Early Study Shows MHRP Vaccine Candidate, MVA-CMDR, Safe and Immunogenic
Early antiretroviral therapy dramatically reduces HIV DNA set point
Early-Capture HIV Study Allows for Characterization of Acute Infection Period
Family day at an HIV clinic in Tanzania
Findings from WRAIR-NIAID EBOV Clinical Trial Published in NEJM
Findings from WRAIR-NIAID EBOV Clinical Trial Published in NEJM
Army-developed Zika Vaccine Induces Strong Immune Response in Three Phase 1 Studies
Characterization of T Cells Infected with Simian Immunodeficiency Virus Reveals Host-pathogen Interactions
DREAMS Work in Mbeya Provides a Path Out of Prostitution
Experimental Vaccine Blocks Effects of Heroin in Mice
MHRP Scientists and Collaborators Presenting at CROI 2018
MHRP Scientists and Collaborators at the ASTMH Annual Meeting
RNA Signatures of Natural Killer Immune Cells Suggest Increased Activity Following HIV Vaccination
Social Science Research Involving MHRP Acute HIV Infection Cohort Seeks to Understand Volunteers' Perspectives in Treatment Interruption Studies
Study Links Gut-Homing Protein Levels With HIV Infection Risk, Disease Progression
World AIDS Day 2017
Clinical Training Course in Liberia Boosts Biopreparedness Efforts in West Africa
Col. Nelson Michael Selected as One of Vice Motherboard’s ‘Humans of the Year’
Diagnosis of Acute HIV Infection and Immediate Treatment Reduces Transmission by 89% in Thai Cohort
Dr. Carl Alving Inducted as National Academy of Inventors Fellow
Dr. Lydie Trautmann Awarded R01 Grant from National Institute of Mental Health
Dual-use Heroin Vaccine Elicits Immune Response in Mice
Experts identify challenges to fast-track development of Zika vaccine
First Public Meeting of Cross-Sector HIV Cure Project
Human Trials Begin for Army-Developed Zika Purified Inactivated Virus (ZPIV) Vaccine
Initiating ART During Acute HIV Infection Affects Trajectory of Viral Load
Insight into Acute HIV Infection
Investigational HIV Therapeutic Vaccine Approach Helps Control SIV in Preclinical Studies
Joint West Africa Research Group Begins Infectious Disease Surveillance Study in Nigeria
Koome Island Demonstration Farm Helps Support Women and Families
Late HIV Vaccine Boost Elicits Higher Immune Response in Volunteers from the RV144 Thai Trial
MHRP Researchers and Collaborators Presenting at CROI 2017
MHRP Welcomes Dr. M. Gordon Joyce, Chief of New Structural Biology Lab Section
MHRP and Collaborators at HIV Research for Prevention (HIVR4P) 2016
MHRP and Collaborators at the 9th IAS Conference on HIV Science
MHRP scientists and collaborators detect declining trend in transmitted drug resistance in acute HIV infection cohort
New MHRP PEPFAR-funded study to examine malaria and TB HIV co-infection in Kenyan Defence Forces
New Multi-site Phase 2 Ebola Vaccine Study Begins in Africa
New Study Provides Clues to Early T Cell Immune Responses in Acute HIV Infection
Nigeria Biopreparedness Initiative Launches with Laboratory Training and Site Assessment
Nigeria Study Identifies Potential Cohorts for HIV Vaccine Development
U.S. Officials Visit with Participants in DREAMS Program
World AIDS Day 2016: Reinvigorating the Field
World TB Day: MHRP Research Physician Focuses on Problem of TB/HIV Co-infection
First-in-Human Phase 1 Clinical Trial of MERS Vaccine Begins
Fitness training and events help increase HIV prevention awareness in Kenya
Follow-up Study to RV144 HIV Vaccine Trial Shows No Effect on Disease Progression in Infected Volunteers
Former MHRP Leader Selected as Next U.S. Global AIDS Coordinator
Former MHRP Leader Selected as Next U.S. Global AIDS Coordinator
Future of HIV Cure Research Points to Combination Approach
HIV Infant Tracking System (HITSystem) Improves Early Infant Diagnosis Outcomes for HIV-Exposed Infants in Tanzania
HIV Prevention, Care and Treatment Open House Draws Thousands to Tanzania's Southern Highlands
HIV Vaccine Awareness Day 2009
HIV Vaccine Awareness Day 2010
HIV Vaccine Awareness Day 2011
HIV Vaccine Awareness Day 2011 Activities
HIV Vaccine Awareness Day: Building on the Success of RV144
HIV Vaccine Development and the US Military
HIV Vaccine Development and the US Military
HIV Vaccine Research Center of Excellence to Open at AFRIMS
HIV-1 Immune Evasion Mutations Could Impact Future Vaccine Efficacy
How the Military is Engaged in the Battle Against Malaria
How the Military is Engaged in the Battle Against Malaria
Human Clinical Trial of DNA-MVA HIV Vaccine Candidate Begins
Human Clinical Trial of a New DNA-MVA Vaccine Candidate Begins in Africa
Human Genetic Studies Underscore Similarities Among East African Populations
Humanized DRAG Mouse Model Holds Promise For Pre-Clinical Testing of Candidate HIV Vaccines
IRIS Study Opens in Kericho, Kenya
Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya
In Memory of Sen. Daniel K. Inouye
In Memory of our Nigerian Colleagues
In South Africa, RV144 HIV Vaccine Regimen Induces Immune Responses Similiar to Those Seen in Thailand
In Uganda, MHRP Researchers Find Viral Burden to be Primary Predictor of HIV Disease Progression
In Uganda, MHRP Researchers Find Viral Burden to be Primary Predictor of HIV Disease Progression
Infection with Multiple HIV-1 Variants Leads to Poorer Clinical Outcomes
Initiation of ART during Acute HIV Infection Leads to High Rate of Non-Reactive HIV Serology
Innovative "Moonlight" HIV Counseling and Testing
Interview with Ambassador Goosby, U.S. Global AIDS Coordinator
Joint West Africa Research Group to Foster Biopreparedness
Joint West Africa research Group Completes First Training in Nigeria
Laboratory Studies Provide Possible Explanation for How the RV144 Vaccine Regimen May Have Protected Against HIV
Laboratory Training Program Brings Together MHRP, Nigerian Military and the U.S. Public Health Service
Lancet Article Explores Efficacy Variables in RV144
Large Multinational HIV Cohort Study Begins in Africa
Long-term Adverse Health Effects of Ebola Survivors Examined in New Lancet ID Paper
MHRP Collaborates with Maryland's Institute of Human Virology on Promising HIV/AIDS Vaccine Candidate
MHRP Community Engagement Meeting held in Uganda
MHRP Congratulates COL Jerome Kim on Top IVI Appointment
MHRP Congratulates COL Jerome Kim on Top IVI Appointment
MHRP Congratulates COL Jerome Kim on Top IVI Appointment
MHRP Congratulates COL Jerome Kim on Top IVI Appointment
MHRP Deputy Col. Jerome Kim Receives Award for Research Excellence
MHRP Diagnostics: A Unique Capability within the DoD
MHRP Diagnostics: A Unique Capability within the DoD
MHRP Director receives the Hero of Military Medicine Award for the U.S. Army
MHRP Kenya Country Director Receives Prestigious Military Civilian Award
MHRP Launches New Quarterly Newsletter
MHRP Leadership Meets with the President of Tanzania
MHRP Marks HIV Vaccine Awareness Day
MHRP Named a Clinical Trials Unit for NIH HIV/AIDS Clinical Trials Networks
MHRP Partners with Tanzanian People's Defense Forces to Open HIV Counseling and Testing Center
MHRP Profiles
MHRP Profiles
MHRP Profiles: Ebola Vaccine Trial Participant
MHRP Researcher Receives HIV Prevention Research Advocacy Fellowship
MHRP Researchers Provide Insight into Worlds Most Potent Vaccine Adjuvant
MHRP Researchers Provide Insight into Worlds Most Potent Vaccine Adjuvant
MHRP Researchers find Host Genetics Played a Role in RV144 Protection
MHRP Researchers find Host Genetics Played a Role in RV144 Protection
MHRP Scientist Discusses WHO Ebola Collaboration
MHRP Scientist Wins 2012 NIDA Avant-Garde Award for Combination Anti-Heroin/HIV Vaccine
MHRP Scientists Take Part in AIDS Vaccine 2010 Conference in Atlanta
MHRP Scientists and Collaborators Presenting at AIDS 2016
MHRP Scientists and Collaborators Presenting at CROI 2016
MHRP Welcomes Dr. Hendrik Streeck
MHRP Welcomes Dr. Jintanat Ananworanich as Associate Director for Therapeutics Research
MHRP Welcomes Lydie Trautmann, Chief of Cellular Immunology
MHRP Welcomes Lydie Trautmann, Chief of Cellular Immunology
MHRP and Collaborators Presenting at Keystone Symposia HIV Vaccine and HIV Persistence Meetings
MHRP and Colleagues Featured in Special JAIDS Supplement
MHRP at AIDS Vaccine 2013
MHRP at CROI 2014
MHRP at CROI 2014
MHRP at HIV Research for Prevenetion (R4P) 2014
MHRP at HIV Research for Prevenetion (R4P) 2014
MHRP in the News: September 2011
MHRP selected by the AIDS Clinical Trials Group (ACTG) as a Clinical Trials Unit
MHRP's Administrative Offices Have Moved
MUWRP Celebrates Ten Years of Progress
MUWRP Provides Safe Male Circumcision at Uganda's Parliament Health Week
Making HIV Services More Accessible: MUWRP Refurbishes a Health Centre for the People of Koome Island
Microbicide Gel Shows Reduced Risk of HIV and Herpes Infection in Women
Mobile Diagnostic Lab May Help Combat TB and HIV in Tanzania
Moving Forward this HIV Vaccine Awareness Day
New Clinical Research Center and Comprehensive Care Center Open in Kericho
New Cohort Study Begins in Mozambique
New Cohort Study Begins in Mozambique
New Data from MHRP Study Impacts Rapid Hepatitis C Test Used on Battlefield
New Defence Reference Laboratory Commissioned in Nigeria
New District Youth Center Opens in Uganda
New Ebola vaccine study begins in Nigeria
New HIV Counseling and Testing Clinic Opens in Tanzania
New Insight into Selective Binding Properties of Infectious HIV
New Journal of Virus Eradication Launches Today
New Journal of Virus Eradication Launches Today
New Medical Male Circumcision Program Launched in Uganda
New Mobile Circumcision Clinic is Officially Launched with a Ribbon Cutting Ceremony
New Program in Tanzania Aims to Respond to and Reduce Gender Based Violence
New Report Lauds DoD Overseas Research Laboratories
New Studies Enhance Knowledge of Antibodies in HIV Vaccine Trials
New Studies Enhance Knowledge of Antibodies in HIV Vaccine Trials
New Study Aims to Better Understand Hepatitis Infection in Deployed U.S. Forces
New Study Provides Additional Insights into V2 Antibodies in the RV144 Trial
New Study Shows a Novel Antibody That Binds to Intracellular Lipids and Inhibits HIV Infection
New Study, RV306, Begins Screening in Thailand
New TB Lab Accredited in Tanzania
New findings provide insight into HIV epidemic in the U.S. Army
New study highlights need for Hepatitis C screening for U.S. military
New study shows increase in Kenyan HIV subtypes
New study shows that antibodies seen in RV144 may also correlate with lower risk of infection from multiple HIV subtypes
New study shows that antibodies seen in RV144 may also correlate with lower risk of infection from multiple HIV subtypes
Nigeria Unveils 2012 National HIV Vaccine Plan
OCTANE Study Influences Revision of WHO Guidelines for Treating Some HIV-Infected Women
PEPFAR Program Representatives Gather in Kenya to Share Successes and Plan for the Future
PEPFAR Releases Fifth Annual Report to Congress
PEPFAR's Impact After 10 Years
Paper published on Phase I/II Study of a Vaccine Candidate in East Africa
Patients with Advanced HIV and Tuberculosis May Benefit from Starting Antiretroviral Therapy Early
Phase Ib Ebola/Marburg Vaccine Clinical Trial Begins
Political Engagement: Tanzania
Pox-Protein Public-Private Partnership
Pox-Protein Public-Private Partnership
President's Bioethics Commmission Released Its Report on Human Subjects Protection
Presidential Commission for the Study of Bioethical Issues
Promising Results of Novel Combination HIV Vaccine
Promising Results of Novel Combination HIV Vaccine
Prospects for a Globally Effective HIV-1 Vaccine
Publication Supplements
RV144 Follow-up Study RV305 Begins in Thailand
RV144 Update at CROI
RV144 Vaccine Efficacy Increased Against Certain HIV Viruses
RV144 Vaccine Regimen Tops Best of Lists in 2009
RV144: Further Research is Underway
RV144: The Search for Correlates of Protection Begins
Researchers Design Global HIV Vaccine that Shows Promise in Early Studies
Researchers Determine Factors Associated with Elevated Viral Load Setpoint in Sub-Saharan Africa
Researchers Identify Gene Variant Associated with Protection from HIV in Tanzania
Researchers Identify New Generic Vaccine Adjuvants
Researchers Induce HIV-neutralizing Antibodies by Immunization that Recognize both HIV-1 Envelope Protein and Lipids
Researchers find multiple co-circulating HIV-1 subtypes in North Africa and Middle East
Risk of Acquiring a Transfusion-Transmitted Infection Found to be Low for Military Personnel Who Receive Blood on the Battlefield
SAMRMC Wins Research and Development Lab of the Year
Safe Male Circumcision Services Now Offered at the Mukono Health Center, Uganda
Senior State Department Leadership Visit Nigeria Sites
Socioeconomic Impacts of Antiretroviral Therapy and Gender
State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
State of the ART: HIV Cure, Where Are We Now and Where Are We Going?
Statement from the Military HIV Research Program on World AIDS Day 2011
Statement on World AIDS Day 2012
Study Compares Hospitalization Rates Among HIV Controllers and Those With Medically Controlled HIV in Military Cohort
Study Finds HIV Vaccine Influences the Genetic Makeup of the Virus
Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic in Africa
Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic in Africa
Study finds low ART treatment costs and good retention at clinics in Kenya
TB and HIV: A Deadly Combinaton
TB and HIV: A Deadly Combinaton
Tanzania President Dedicates Mobile Diagnostic Lab
Tanzanian President Jakaya Kikwete Visits the Walter Reed Army Institute of Research
Thai Government To Support HIV Vaccine Study
The Important and Varied Role of Nurses in HIV Research
The Important and Varied Role of Nurses in HIV Research
The U.S. and Tanzanian People's Defence Forces Formalize Arrangement to Conduct HIV Care and Treatment Activities in Tanzania
Time for an HIV Vaccine
Tragic Loss for The HIV Research Community
Tragic Loss for The HIV Research Community
Training for HIV diagnosis and treatment monitoring in Nigeria
Two New Neutralizing Antibodies Discovered
U.S. Ambassador to Nigeria Visits Defense Health Club
U.S. Ambassador to Tanzania Visits MHRP site in Mbeya
U.S. Army Part of Team to Win HIV Cure Research Grant
US Army Announces Results of the Landmark RV144 Trial
US Army Announces Results of the Landmark RV144 Trial
Ugandan Medical Male Circumcision Program Launched to Prevent HIV Transmission
Ugandan Youth Create Murals to Help Promote HIV Prevention
Update on RV144
Vaccine Candidates Protect Against Zika Virus in Rhesus Monkeys
Vaccine Partially Protects Monkeys from HIV-like Infection
Very early seeding of SIV viral reservoir found
Very early seeding of SIV viral reservoir found
WRAIR Teams with Sanofi Pasteur to Co-Develop Zika Virus Vaccine
Walter Reed Army Institute of Research Begins New Phase 2 Clinical Trial of Ebola Vaccine Regimens
Walter Reed Program - Nigeria Celebrates the Opening of a New Office
World AIDS Day 2013
World AIDS Day 2015: The Time to Act is Now
World AIDS Day Events
World AIDS Day: Accelerating the Hunt for An Effective HIV Vaccine
World AIDS Day: Accelerating the Hunt for An Effective HIV Vaccine
World TB Day: MHRP Research Physician Examines Overlap in HIV and Tuberculosis
iPrEx study on Pre-Exposure Prophylaxis (PrEP) Shows Some Effectiveness in Preventing HIV
iPrEx study on Pre-Exposure Prophylaxis (PrEP) Shows Some Effectiveness in Preventing HIV
Careers
Current Positions
Meet Our People
Kim Bonhice
Sandhya Vasan, M.D.
Contact